Valuation: PharmaCorp Rx Inc.

Market Cap 79.78M 57.02M 50.81M 46.47M 42.32M 5.39B 81.93M 558M 223M 2.85B 214M 209M 9B P/E 2026 *
40.5x
P/E 2027 * 13.5x
Enterprise Value 86.38M 61.74M 55.01M 50.32M 45.83M 5.83B 88.71M 605M 242M 3.09B 232M 227M 9.75B EV / Sales 2026 *
1.73x
EV / Sales 2027 * 0.91x
Free-Float
91.69%
Yield 2026 *
-
Yield 2027 * -
1 week-1.22%
Current month+1.25%
1 month-1.22%
3 months-17.35%
6 months-22.12%
Current year-10.99%
1 week 0.38
Extreme 0.385
0.42
1 month 0.38
Extreme 0.375
0.44
Current year 0.38
Extreme 0.375
0.58
1 year 0.38
Extreme 0.375
0.58
3 years 0.38
Extreme 0.375
0.88
5 years 0.12
Extreme 0.12
0.88
10 years 0.12
Extreme 0.12
0.88
Date Insider Type Main position Quantity % Market Cap. Importance
7/14/26 Buy

Chief Executive Officer

172,942 0.0993%
7/14/26 Buy

Founder

173,333 0.0996%
7/14/26 Buy

Chairperson

173,333 0.0996%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.22%-15.62%+92.86% 57.14M
-0.69%+12.70%-29.61%+10.81% 16.29B
-4.07%+5.43%-10.77%+8.69% 6.66B
-3.04%+2.86%-4.71%+2.02% 6.53B
-1.11%+10.09%-45.72%-37.55% 6.09B
-19.95%-5.23%-25.82%-40.94% 4.91B
-0.07%+5.87%+14.11%-10.52% 4.85B
+1.12%+12.49%+12.00%-16.99% 3.5B
+2.54%+1.97%-17.70%-30.60% 3.14B
+3.76%+9.35%-35.50%-20.05% 3.12B
Average -2.16%+3.51%-15.93%-4.23% 5.51B
Weighted average by Cap. -2.54%+5.65%-18.98%-8.09%

Financials

2026 *2027 *
Net sales 49.96M 35.71M 31.82M 29.1M 26.51M 3.37B 51.31M 350M 140M 1.79B 134M 131M 5.64B 95.97M 68.59M 61.12M 55.9M 50.91M 6.48B 98.56M 672M 269M 3.43B 257M 252M 10.83B
Net income 1.5M 1.07M 955K 874K 796K 101M 1.54M 10.5M 4.2M 53.65M 4.02M 3.94M 169M 6.7M 4.79M 4.27M 3.9M 3.55M 453M 6.88M 46.89M 18.75M 240M 17.97M 17.59M 756M
Net Debt 6.6M 4.72M 4.21M 3.85M 3.5M 446M 6.78M 46.21M 18.48M 236M 17.71M 17.33M 745M 7.45M 5.33M 4.75M 4.34M 3.95M 503M 7.65M 52.14M 20.85M 267M 19.99M 19.56M 841M
Projected Income Statement - Annual - PharmaCorp Rx Inc.
Logo PharmaCorp Rx Inc.
PharmaCorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. The Company operates approximately 17 PharmaChoice Canada-bannered pharmacies. It focuses on acquiring both PharmaChoice Canada bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform in accordance with its strategic alliance with PharmaChoice Canada.
Employees
-
Date Price Change Volume
26-11-05 $0.4050 0.00% 104,362
26-11-04 $0.4050 -1.22% 12,600
26-11-03 $0.4100 0.00% 30,600
26-11-02 $0.4100 +2.50% 1,170
26-10-30 $0.4000 -2.44% 2,822
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - PharmaCorp Rx Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.4050CAD
Average target price
0.6667CAD
Spread / Average Target
+64.61%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PharmaCorp Rx Inc.
  1. Stock Market
  2. Stocks
  3. PCRX Stock